Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting.

Thiam S, Ndiaye JL, Diallo I, Gatonga P, Fall FB, Diallo NE, Faye B, Diouf ML, Ndiop M, Diouf MB, Gaye O, Thior M.

Malar J. 2013 Feb 5;12:54. doi: 10.1186/1475-2875-12-54.

2.

Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal.

Brasseur P, Vaillant MT, Olliaro PL.

Malar J. 2012 Dec 5;11:402. doi: 10.1186/1475-2875-11-402.

3.

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

Malar J. 2009 Jan 5;8:2. doi: 10.1186/1475-2875-8-2.

4.
5.

Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.

Mehta U, Durrheim D, Mabuza A, Blumberg L, Allen E, Barnes KI.

Drug Saf. 2007;30(10):899-910.

PMID:
17867727
6.

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon.

Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P.

Malar J. 2009 Jul 29;8:176. doi: 10.1186/1475-2875-8-176.

7.

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.

Kabanywanyi AM, Mulure N, Migoha C, Malila A, Lengeler C, Schlienger R, Genton B.

Malar J. 2010 Jul 14;9:205. doi: 10.1186/1475-2875-9-205.

8.

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.

Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P.

Malar J. 2009 Jul 29;8:174. doi: 10.1186/1475-2875-8-174.

9.

Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.

Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M.

BMC Infect Dis. 2008 Mar 28;8:39. doi: 10.1186/1471-2334-8-39. Review.

10.

Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.

Dellicour S, Brasseur P, Thorn P, Gaye O, Olliaro P, Badiane M, Stergachis A, ter Kuile FO.

Drug Saf. 2013 Jul;36(7):505-13. doi: 10.1007/s40264-013-0059-1.

PMID:
23673815
12.

Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal.

Thiam S, Thwing J, Diallo I, Fall FB, Diouf MB, Perry R, Ndiop M, Diouf ML, Cisse MM, Diaw MM, Thior M.

Malar J. 2012 Sep 25;11:334. doi: 10.1186/1475-2875-11-334.

13.

Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.

Menan H, Faye O, Same-Ekobo A, Oga AS, Faye B, Kiki Barro CP, Kuete T, N'diaye JL, Vicky AM, Tine R, Yavo W, Kane D, Kassi KF, Kone M.

Malar J. 2011 Jul 8;10:185. doi: 10.1186/1475-2875-10-185.

14.

Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.

Dodoo AN, Fogg C, Nartey ET, Ferreira GL, Adjei GO, Kudzi W, Sulley AM, Kodua A, Ofori-Adjei D.

Drug Saf. 2014 Jun;37(6):433-48. doi: 10.1007/s40264-014-0164-9.

PMID:
24788801
15.
17.
18.

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.

Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G.

Clin Infect Dis. 2008 Apr 1;46(7):985-91. doi: 10.1086/529192.

PMID:
18444813
19.

Pharmacovigilance of antimalarial treatment in Africa: is it possible?

Talisuna AO, Staedke SG, D'Alessandro U.

Malar J. 2006 Jun 16;5:50.

20.

Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria.

Kukula VA, Dodoo AA, Akpakli J, Narh-Bana SA, Clerk C, Adjei A, Awini E, Manye S, Nagai RA, Odonkor G, Nikoi C, Adjuik M, Akweongo P, Baiden R, Ogutu B, Binka F, Gyapong M.

Malar J. 2015 Oct 19;14:411. doi: 10.1186/s12936-015-0932-8.

Supplemental Content

Support Center